Latham & Watkins represented Corinthian Capital in the transaction. Corinthian Capital Management, LLC, an affiliate of Corinthian Capital Group, LLC, has announced the closing of the acquisition...
You must be a Standard 1 Year member to access this content.
White & Case is acting as U.S. legal counsel to Air Water Ventures Ltd., and Latham & Watkins is acting as U.S. legal counsel to Athena...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Cochran in the case. In an historic ruling, the U.S. Supreme Court this morning held that Texas Accountant Michelle Cochran has the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Immuneering in the offering, while Sidley Austin represented the underwriters involved. Immuneering Corporation (Nasdaq: IMRX) announced the pricing of its underwritten offering...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering. TELA Bio, Inc. has announced the pricing of its previously announced underwritten...
You must be a Standard 1 Year member to access this content.
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Azora on the deal. Azora announced its $13.5 million strategic minority stake in Abatable, a carbon procurement and market intelligence platform for the...
You must be a Standard 1 Year member to access this content.
Willkie Farr advised Take-Two, and Latham & Watkins advised the underwriters. Take-Two Interactive Software, Inc. closed its underwritten public offering of $1 billion aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Crandon Law served as counsel to TORL BioTherapeutics, and Latham & Watkins served as counsel to Goldman, Sachs & Co. TORL BioTherapeutics LLC has announced its...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Sobi in the transaction. Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Chimera Abu Dhabi on the deal. Chimera Abu Dhabi announced its joint venture with Haeres Capital to create ChimHaeres Investment Holding, an investment...
You must be a Standard 1 Year member to access this content.
